Skip to main content

Table 3 Comparison between the two studied groups according to serum miRNA 486-5p and AFP

From: Role of serum micro-RNA 486-5p in Egyptian cirrhotic hepatitis C patients with hepatocellular carcinoma

 

Without (n = 25)

HCC (n = 25)

U

p

miRNA 486-5p

 Min.–Max

0.01–18.64

0.16–1147

110.0*

< 0.001*

 Median (IQR)

0.66 (0.14–0.97)

2.59 (1.13–68.59)

AFP

 Min.–Max

1.60–300

4.40–1210

180.0*

0.010*

 Median (IQR)

8.6 (3.4–12.3)

68 (9.1–155)

  1. Min minimum, Max maximum
  2. *Statistically significant at p ≤ 0.05